Skip to content
biotechnology hero image
biotechnology hero image

Biotechnology

Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.

Our team benefits from having several members of the group who have completed degrees in subjects including molecular biology, biochemistry and genetics. This knowledge enables us to quickly grasp technical concepts and provide nuanced and tailored advice.

We closely follow new developments and emerging trends in the biotech market. For example, we have been following the emerging regulatory pathways for biosimilars and advising clients on appropriate strategies.

We have worked with many well-known companies on their biological products, including Pfizer, Novartis, Regeneron, Amgen and Roche.

News & insights

Windows on a modern glass and metal building

Publications: 07 OCTOBER 2021

Record-breaking M&A run continues at pace

Dealmaking across the globe continues to break records, as investors take advantage of benign market conditions to deploy capital at an accelerating pace.

Read more
meeting discussion

Publications: 06 OCTOBER 2021

Podcast: The injunction gap, proportionality and final injunctions: legislative updates in Germany

How will recent legislative updates in Germany affect patent litigation?

Read more
Image of Dario de Martino

News: 21 SEPTEMBER 2021

Leading Tech M&A Partner Dario de Martino Joins Allen & Overy’s U.S. M&A Practice

Allen & Overy today announced that Dario de Martino has joined the firm as a partner in its M&A practice, based in New York. Dario joins from Morrison & Foerster LLP, where he was a partner in the M&A…

Read more
Vials of medication during production

Publications: 15 DECEMBER 2020

Healthcare accent is on smaller deals

Transactions in the U.S. healthcare space rebounded in autumn, although with a greater proportion of smaller deals than in recent years. 

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.